Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fnagi.2026.1971059.s001BackgroundIdiopathic normal pressure hydrocephalus (iNPH) is an age-associated neurological disorder characterized by gait disturbance, cognitive impairment, and urinary dysfunction. Although cerebrospinal fluid dynamics are central to its pathophysiology, the contribution of peripheral immune alterations remains poorly understood. We characterized an interferon-response-high monocyte state observed in iNPH and evaluated computational compound prioritization.MethodsWe used a fixed set of marker criteria to characterize the IFN-response-high monocyte state. We then compared monocyte clusters 5 and 0 and used 150 upregulated and 150 downregulated genes to screen compounds in LINCS. We tested whether candidate rankings changed with different state definitions, comparison groups, gene-list sizes, clustering settings, and inclusion of all patients. We also repeated the queries after excluding each donor while retaining the original cell-state labels and compared the results with 100 expression-matched random gene signatures. External blood datasets and paired blood–ventricular CSF samples provided additional context.ResultsThe marker rule classified 3,195 of 22,197 canonical monocytes as IFN-response-high. The cluster contrast identified 1,231 FDR-significant genes. Of 1,376 THP1 compounds, 138 met the operational criteria of normalized connectivity score (NCS) ConclusionThis study characterizes an interferon-response-high classical-monocyte state observed within an iNPH cohort and nominates compounds with predicted inverse connectivity for experimental testing. Computational support was more consistent for rosuvastatin than for roflumilast. These findings support further investigation of peripheral innate immune states observed in an iNPH cohort and provide experimentally testable hypotheses for therapeutic repurposing.
Keyword(s):
drug repurposing; idiopathic normal pressure hydrocephalus; LINCS L1000; monocytes; neuroinflammation.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)